Jefferies Group's position in Sanofi is currently worth $557k. That's 0.01% of their equity portfolio (840th largest holding). The first Sanofi trade was made in Q3 2023. Since then Jefferies Group bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $606k, resulting in a loss of 8.1%.
Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page o...
Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab)...
Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023Distribution of a cash dividend of €3.76 per share, wit...
Sanofi - Aventis Groupe said results from the LUNA 3 phase 3 study showed that rilzabrutinib 400 mg twice daily orally achieved the primary endpoint of durab...